Quintrio
Home

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ImageneBio, Inc. Common Stock

IMA

ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.

Last trade $3.50
Day change +$0.30 (+9.37%)
Day range $3.12 – $4.03
Volume 74,995
Market cap $40M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$39.86M
Price / earnings
—
Price / book
0.31×
Price / sales
—
EV / sales
—
EV / EBITDA
0.91×

Profitability

Earnings per share
-$3.48
Return on assets
-30.39%
Return on equity
-33.81%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
16.17×
Quick ratio
16.17×
Cash ratio
10.51×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$40.61M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for IMA, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025
Revenue$0$0$0$0$0
Cost of revenue$0$0$0$0$0
Gross profit$0$0$0$0$0
Selling, general and administrative$6.04M$5.12M$6.12M$5.23M$11.04M
Research and development$11.27M$6.67M$5.96M$3.27M$15.16M
Total operating expenses$17.31M$11.78M$12.08M$8.5M$26.19M
Operating income-$17.31M-$11.78M-$12.08M-$8.5M-$26.19M
Interest expense$1.19M$1.25M$1.13M$0$1.06M
Income before taxes-$15.6M-$10.16M-$10.61M-$7.18M-$24.85M
Income taxes$20K$16K$10K-$276K-$74K
Net income-$15.62M-$10.18M-$10.62M-$6.91M-$24.78M
Net income attributable to common shareholders-$15.62M-$10.18M-$10.62M-$6.91M-$25.63M
EBITDA-$17.31M-$11.78M-$12.08M-$8.11M-$26.19M
Basic earnings per share-$0.91-$0.63-$0.95-$1.18-$2.91
Diluted earnings per share-$0.91-$0.63-$0.95-$1.18-$2.91

Recent news

Company coverage with links to the original publishers.

Publication times in UTC

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily

No stock split records found.